Autopsy report · NCT03197025
Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Cause of deathFunding or business
“The study was closed due to investigator discretion based on the lack of perceived clinical activity observed in the study.”
Life of this trial
- Registered 7 months before it started.
- Ran for about 2 years 9 months before it stopped.
- 1 participant enrolled.
- Results were posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Human Papillomavirus; HPV-16; High Grade Squamous Intraepithelial Lesion
- Interventions
- Aldesleukin; E6 T Cell Receptor (TCR)
- Participants
- 1
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
“This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.” - A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
“Study closed due to slow accrual and lack of efficacy.” - Exenatide For Reducing the Reinforcing Effects of Cocaine
“The study was closed due to the inability to acquire the study drug.” - Reiki for the Management of Neuropathic Pain
“Study closed due to substantial decrease in the desired patient population.” - Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
“Closed due to patient recruitment challenges. No interim analyses were completed; study closure was not related to any concerns about safety or futility.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.